Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin’s Lymphoma

Press release content from PR Newswire. The AP news staff was not involved in its creation. https://apnews.com/press-release/PR%2520Newswire/5d3644900c8888618388e38979faf1f9 Click to copy SHANGHAI and PHILADELPHIA, April 14, 2020 /PRNewswire/ — Antengene announced today that it has dosed the first patient in Taiwan, China in its phase 1 open-label clinical trial of ATG-019 (KPT-9274), a dual inhibitor of both PAK4 and NAMPT. This...

READ MORE Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin’s Lymphoma

Adenine definition and meaning

[#item_title] 7 Shakespearean words to add to your vocabulary It’s English Language Day! The annual event where language lovers come together to celebrate the great William Shakespeare and a chance to celebrate multilingualism in English-speaking countries around the globe. We’re celebrating with this list of 7 Shakespearean words to weave into your vocabulary. Without further ado, let us go forth....

READ MORE Adenine definition and meaning

North America DNA Sequencing Products Market Expected to Grow with a CAGR of 15.2% During the Forecast Period, 2019-2024

DUBLIN–(BUSINESS WIRE)–Jan 14, 2020– The “North America DNA Sequencing Products Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”[1] report has been added to ResearchAndMarkets.com’s offering. The publisher expects the market to reach a value of US$ 3.34 Billion by 2024, registering a CAGR of 15.2% during 2019-2024. The North America DNA sequencing products market reached a value of...

READ MORE North America DNA Sequencing Products Market Expected to Grow with a CAGR of 15.2% During the Forecast Period, 2019-2024

PRESS RELEASE – A hug against cancer

21.11.2018 Defeating cancer with a hug is possible. It’s science suggesting it, in an article published in the prestigious international journal Nucleic Acids Research. Scientists observed that the “embrace” between the antitumor molecule Actinomicin D (ActD) with some structures of our DNA can inhibit the activity of enzymes linked to the replication of cancer cells through a stabilizing action, providing...

READ MORE PRESS RELEASE – A hug against cancer

Generated by Feedzy